Measuring insulin levels and insulin resistance in adults with PCOS and obesity

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 or older, with or without PCOS, who recently had fasting blood tests that include insulin.

Age

18 years or older

Sex

Men and women can both join.

Disease stage

People with and without a confirmed PCOS diagnosis, across a range of body mass index (BMI) values.

Biomarker or test result

Blood tests done within one month before joining after a fast of at least 8 hours: fasting insulin, hemoglobin A1c, a complete lipid panel and triglycerides. All results must be available.

Main reasons for not taking part

• Under 18 years old
• Another hormone disorder that affects insulin levels (for example insulin-secreting tumors)
• Loss of more than 5% of body weight within the previous month
• Pregnancy or breastfeeding
• Acute illness or infection within the past 2 weeks

The registry criteria, word for word

What the trial wants to find out

The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.